Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Division of Molecular Oncology
Federico Caligaris-Cappio has not added Biography.
If you are Federico Caligaris-Cappio and would like to personalize this page please email our Author Liaison for assistance.
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.
Nature medicine Jun, 2014 | Pubmed ID: 24813251
Anergy: the CLL cell limbo.
Blood May, 2014 | Pubmed ID: 24855189
SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.
Haematologica Aug, 2014 | Pubmed ID: 24859880
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
The New England journal of medicine Jul, 2014 | Pubmed ID: 24881631
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
British journal of haematology Oct, 2014 | Pubmed ID: 25312994
IRCCS, San Raffaele Scientific Institute
Università Vita-Salute San Raffaele
Benedetta Apollonio1,2,
Maria Teresa Sabrina Bertilaccio1,
Umberto Restuccia3,
Pamela Ranghetti1,
Federica Barbaglio1,
Paolo Ghia1,4,
Federico Caligaris-Cappio1,4,
Cristina Scielzo1
1Division of Molecular Oncology, IRCCS, San Raffaele Scientific Institute,
2Department of Haemato-Oncology, King's College London,
3, IFOM, FIRC Institute of Molecular Oncology,
4, Università Vita-Salute San Raffaele
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.